Final results of Boceprevir early access for advanced fibrosis/cirrhosis in Asia-Pacific HCV genotype 1 non-responders/relapser patients (Beacon Study).

Wattana Sukeepaisarnjaroen, Tri Pham, Tawesak Tanwandee, Saroja Nazareth, Sam Galhenage, Lindsay Mollison, Leanne Totten, Alan Wigg, Rosalie Altus, Anton Colman, Brenda Morales, Susan Mason, Tracey Jones, Nadine Leembruggen, Vince Fragomelli, Cheryl Sendall, Richard Guan, Dede Sutedja, Soek Tan, Yock DanYin-Mei Lee, Widjaja Luman, Eng Teo, Yin Than, Teerha Piratvisuth, Seng Lim

Research output: Contribution to journal › Meeting Abstract › peer-review

Fingerprint

Dive into the research topics of 'Final results of Boceprevir early access for advanced fibrosis/cirrhosis in Asia-Pacific HCV genotype 1 non-responders/relapser patients (Beacon Study).'. Together they form a unique fingerprint.

Medicine & Life Sciences